PreciousMD ltd

PreciousMD technologies merge artificial intelligence capabilities with medical imaging to formulate diagnostic approaches beyond what human experts can provide. Due to the high mortality rate and massive public cost burden of lung cancer, PreciousMD has focused on this type of cancer at the starting point. PreciousMD team is consist of a high profile data scientists, image processing specialists, radiologists, clinical trial, artificial intelligence professionals, specialists, and commercial/business management experts from the University of Manchester, Oxford, and Cambridge. We intend for PreciousMD technologies to become a routine part of clinical practice and drug development and substantially improve the way of addressing cancer.